Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Down 61.5% in May

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 1,000 shares, a decline of 61.5% from the May 15th total of 2,600 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is presently 0.3 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Harrow Health, Inc. 11.875% Senior Notes due 2027 stock traded up $0.04 during midday trading on Friday, reaching $26.05. The stock had a trading volume of 1,543 shares, compared to its average volume of 3,620. The company has a fifty day moving average of $26.24 and a 200 day moving average of $26.40. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52-week low of $24.90 and a 52-week high of $27.70.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 30th. Shareholders of record on Tuesday, April 15th were given a $0.7422 dividend. This represents a $2.97 annualized dividend and a yield of 11.40%. The ex-dividend date of this dividend was Tuesday, April 15th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.